10-104045739-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000494.4(COL17A1):c.2398+19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.511 in 1,597,748 control chromosomes in the GnomAD database, including 213,734 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.44 ( 16096 hom., cov: 33)
Exomes 𝑓: 0.52 ( 197638 hom. )
Consequence
COL17A1
NM_000494.4 intron
NM_000494.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.535
Publications
6 publications found
Genes affected
COL17A1 (HGNC:2194): (collagen type XVII alpha 1 chain) This gene encodes the alpha chain of type XVII collagen. Unlike most collagens, collagen XVII is a transmembrane protein. Collagen XVII is a structural component of hemidesmosomes, multiprotein complexes at the dermal-epidermal basement membrane zone that mediate adhesion of keratinocytes to the underlying membrane. Mutations in this gene are associated with both generalized atrophic benign and junctional epidermolysis bullosa. Two homotrimeric forms of type XVII collagen exist. The full length form is the transmembrane protein. A soluble form, referred to as either ectodomain or LAD-1, is generated by proteolytic processing of the full length form. [provided by RefSeq, Jul 2008]
COL17A1 Gene-Disease associations (from GenCC):
- epithelial recurrent erosion dystrophyInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
- epidermolysis bullosa, junctional 4, intermediateInheritance: AR Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
- junctional epidermolysis bullosa, non-Herlitz typeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- amelogenesis imperfectaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- generalized junctional epidermolysis bullosa non-Herlitz typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- late-onset junctional epidermolysis bullosaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- localized junctional epidermolysis bullosa, non-Herlitz typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-104045739-C-T is Benign according to our data. Variant chr10-104045739-C-T is described in ClinVar as Benign. ClinVar VariationId is 256268.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.657 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL17A1 | NM_000494.4 | c.2398+19G>A | intron_variant | Intron 33 of 55 | ENST00000648076.2 | NP_000485.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.440 AC: 66911AN: 152078Hom.: 16106 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
66911
AN:
152078
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.498 AC: 125171AN: 251378 AF XY: 0.501 show subpopulations
GnomAD2 exomes
AF:
AC:
125171
AN:
251378
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.519 AC: 750323AN: 1445552Hom.: 197638 Cov.: 31 AF XY: 0.518 AC XY: 373200AN XY: 720156 show subpopulations
GnomAD4 exome
AF:
AC:
750323
AN:
1445552
Hom.:
Cov.:
31
AF XY:
AC XY:
373200
AN XY:
720156
show subpopulations
African (AFR)
AF:
AC:
7300
AN:
33246
American (AMR)
AF:
AC:
20959
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
AC:
12711
AN:
26054
East Asian (EAS)
AF:
AC:
26889
AN:
39610
South Asian (SAS)
AF:
AC:
40647
AN:
85934
European-Finnish (FIN)
AF:
AC:
26046
AN:
53356
Middle Eastern (MID)
AF:
AC:
2595
AN:
5730
European-Non Finnish (NFE)
AF:
AC:
582918
AN:
1097008
Other (OTH)
AF:
AC:
30258
AN:
59906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
16921
33842
50762
67683
84604
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
16512
33024
49536
66048
82560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.440 AC: 66895AN: 152196Hom.: 16096 Cov.: 33 AF XY: 0.439 AC XY: 32685AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
66895
AN:
152196
Hom.:
Cov.:
33
AF XY:
AC XY:
32685
AN XY:
74432
show subpopulations
African (AFR)
AF:
AC:
9913
AN:
41518
American (AMR)
AF:
AC:
6850
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1750
AN:
3472
East Asian (EAS)
AF:
AC:
3502
AN:
5180
South Asian (SAS)
AF:
AC:
2172
AN:
4824
European-Finnish (FIN)
AF:
AC:
5198
AN:
10598
Middle Eastern (MID)
AF:
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
AC:
35883
AN:
67998
Other (OTH)
AF:
AC:
954
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1836
3672
5507
7343
9179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
616
1232
1848
2464
3080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1746
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Junctional epidermolysis bullosa, non-Herlitz type Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epithelial recurrent erosion dystrophy Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.